Home / Dabigatran Etexilate / Belgium
BE ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Belgium
Is there a Dabigatran Etexilate shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Dabigatran Etexilate products are reported short in Belgium, the first since 9 Feb 2026. The company estimate for the return is 14 Dec 2026 (latest 8 Mar 2027). Main reason: active ingredient shortage.
Also short in Canada, Germany, Italy, Spain, Austria, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Dabigatran Etexilate Viatris 110 mg hard caps. 180 | Viatris GX | 9 Feb 2026 | 14 Dec 2026 | Active ingredient shortage Active Substance not available |
| BE | Dabigatran Etexilate Viatris 150 mg hard caps. 60 (60 x 1) UD | Viatris GX | 25 Aug 2026 | 14 Dec 2026 | Manufacturing problem Delay in production |
| BE | Dabigatran Etexilate Viatris 110 mg hard caps. 60 (60 x 1) UD | Viatris GX | 26 Oct 2026 | 8 Mar 2027 | Increased demand |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.